---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-002645"
form_type: "8-K"
ticker: "CELZ"
cik: "0001187953"
company_name: "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T15:56:20.033244+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Creative Medical receives Nasdaq notice for late clawback policy adoption; matter closed as now compliant.

## Summary
- On April 8, 2025, Nasdaq notified Creative Medical for failure to timely adopt and disclose Clawback Policy per Listing Rule 5608.
- Company adopted policy on April 4, 2025 with retroactive effect to Dec 1, 2023; no incentive compensation affected.
- Nasdaq confirmed company currently in compliance and matter is closed.

## SEC filing metadata
- accession: 0001477932-25-002645
- form_type: 8-K
- ticker: CELZ
- cik: 0001187953
- company_name: CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1187953/000147793225002645/0001477932-25-002645-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1187953/000147793225002645/celz_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-002645
- JSON: https://secwatch.observer/filing/0001477932-25-002645.json
- Plain text: https://secwatch.observer/filing/0001477932-25-002645.txt

## Key facts
- Listing & Compliance Notices
  CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. received a nasdaq deficiency notice notice regarding other (rules 5608(b)(1), 5608(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Rules: 5608(b)(1), 5608(b)(2)
  source text: April 8, 2025, the Company received a letter from Nasdaq stating that because the Company failed to timely adopt the Policy as required by Listing Rule 5608(b)(1), and failed to disclose the Policy in its Form 10-K for the fiscal years ended December 31, 2023 or December 31, 2024 (prior to its amendment), the Company previously did not comply with Listing Rule 5608(b)(2). However, in the letter, Nasdaq further informed the Company that it is currently in compliance with Nasdaq Listing Rules, and the matter raised by Nasdaq in the letter is now closed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1187953/000147793225002645/0001477932-25-002645-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.